The following table is for layout only Goto Main Navigation | Goto Main Content | Goto Banner | Goto Logon Box | Goto Menu Bar | Goto Search Box | Goto Footer
 

 
Register
|
Return to Listing
Rituximab in combination with Fludarabine and Cyclophosphamide (FCR) for a patient with relapsed chronic lymphocytic leukaemia (CLL), and who was previously been treated with FCR in 2004
URL/File
 Rituximab combined with FCR for review s​ummary.doc [83.5K] - Downloaded 4 times. Last downloaded 18 Apr 2012 11:58.
FormatMS Word Document (.doc)
Home LocationLHO
National or RegionalRegional
start of decorative frame for
start of content for
Publication date30 Aug 2009
Creator(s)Islington PCT
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Is part of
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Bendamustine plus rituximab for relapsed chronic lymphocytic leukaemia (CLL)
Rituximab monotherapy for heavily pretreated patient with chronic lymphocytic leukaemia
TA29: Leukaemia (lymphocytic) - fludarabine
TA119: Leukaemia (lymphocytic) - fludarabine
Second line Vinorelbine monotherapy to treat a relapsed patient with epithelioid mesothelioma
More...
end of content for
end of decorative frame for
start of decorative frame for
start of content for
KeywordsClinical exceptions
Exceptional treatments
individual treatments
Lymphocytic leukaemia
Rituximab
end of content for
end of decorative frame for
start of decorative frame for Type and Language
Type and Language
start of content for Type and Language
Resource Typereport
end of content for Type and Language
end of decorative frame for Type and Language